Find where to buy products from UK suppliers, including: distributors, industrial manufacturers, wholesalers, raw ingredients, bulk supplies and finished goods for sale.
Search for products or services, then visit the suppliers website for prices, SDS or more information. You can also view suppliers in Australia, NZ or the USA.
| Product | Description | |
|---|---|---|
| Ceftazidime | 1g Pack Size. Group: Antibiotics, Bioactive Small Molecules. Formula: C22H22N6O7S2. CAS No. 72558-82-8. Prepack ID : 73291468-1g. Molecular Weight : 546.58. |  |
| Ceftazidime Impurities | Ceftazidime Impurities are crucial in the biomedical sector for ensuring the quality and safety of the antibiotic ceftazidime. Monitoring these impurities aids in maintaining efficacy against bacterial infections, particularly Pseudomonas aeruginosa, and helps in compliance with pharmaceutical regulations, thereby safeguarding patient health during treatment. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. |  London |
| Ceftazidime Impurity A | An impurity of Ceftazidime, an antibiotic for certain infection treatment. Group: Pharmaceutical. CAS No. 1000980-60-8. Pack Sizes: 1 mg. Product ID: B2694-468514. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Ceftazidime Impurity G | An impurity of ceftazidime, an antibiotic used for certain infection treatment. Group: Pharmaceutical. CAS No. 194241-83-3. Pack Sizes: 1 mg. Product ID: B2694-468518. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Ceftazidime Impurity H | An impurity of ceftazidime, an antibiotic used for certain infection treatment. Group: Pharmaceutical. CAS No. 1354396-23-8. Pack Sizes: 1 mg. Product ID: B2694-468519. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Ceftazidime Intermediate | An impurity of ceftazidime, an antibiotic used for certain infection treatment. Group: Pharmaceutical. CAS No. 158183-05-2. Pack Sizes: 10 mg. Product ID: B2694-468520. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Ceftazidime pentahydrate | 1g Pack Size. Group: Antibiotics, Bioactive Small Molecules. Formula: C22H32N6O12S2. CAS No. 78439-06-2. Prepack ID : 77145852-1g. Molecular Weight : 636.6525. | |
| Avibactam Impurities | Avibactam impurities, indispensable for evaluating the purity and safety of Avibactam, a non-β-lactam β-lactamase inhibitor, are paramount when combined with antibiotics such as ceftazidime, targeting formidable infections by resistant bacteria. Thorough comprehension of these impurities enhances formulation effectiveness and mitigates adverse effects during therapeutic applications. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Avibactam Sodium Salt | Avibactam Sodium Salt, a novel non-?-lactam ?-lactamase inhibitor, binds covalently to Ambler class A ?-lactamases, including KPCs, Ambler class C and some class D b-lactamases. In combination with ceftazidime, Avibactam is a new drug application for avibactam , and was approved by the FDA on February 25, 2015, to treat complicated urinary tract and complicated intra-abdominal Infections caused by antibiotic resistant-pathogens. Avibactam has limited intrinsic antimicrobial activity but restores the in vitro activity of b-lactams including ceftazidime, ceftaroline, the active metabolite of ceftaroline fosamil, and aztreonam against ESBL-producing pathogens. Group: Pharmaceutical. CAS No. 1192491-61-4. Pack Sizes: 500 mg. Product ID: B0084-465274. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Cefepime hydrochloride hydrate | Cefepime is an extended-spectrum parenteral cephalosporin antibiotic active in vitro against a broad spectrum of gram-positive and gram-negative aerobic bacteria. Cefepime dosing was 1-4 g/day (0.5-2.0 g twice daily) for adults; ceftazidime dosing was 1-6 g/day (0.5 g every 12 hours to 2.0 g every 8 hours). A limited number of cefepime-treated patients received 2 g every 8 hours. The median length of dosing for both cefepime and ceftazidime was 7 days. Cefepime has a decreased propensity to induce beta-lactamases compared with other beta-lactam antibiotics. Cefepime has a pharmacokinetic disposition similar to that of other renally eliminated cephalosporins, with a half-life of approximately 2 hours. Cefepime has demonstrated clinical efficacy against a variety of infections, including urinary tract infections, pneumonia, and skin structure infections. Cefepime is generally well tolerated. Group: Pharmaceutical. CAS No. 123171-59-5. Pack Sizes: 5 g. Product ID: BBF-03810. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
Our database is helping our users find suppliers everyday.
